DCM
BMRN icon

Driehaus Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Driehaus Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,056
Closed -$848K – 552
2015
Q3 		$848K Buy
+8,056
New +$1.08M 0.03% 365
2015
Q1 		– Sell
-14,078
Closed -$1.27M – 500
2014
Q4 		$1.27M Sell
14,078
-10,446
-43% -$869K 0.05% 374
2014
Q3 		$1.77M Buy
+24,524
New +$1.61M 0.07% 348
2014
Q2 		– Sell
-25,018
Closed -$1.71M – 561
2014
Q1 		$1.71M Sell
25,018
-110,718
-82% -$8.16M 0.05% 353
2013
Q4 		$9.54M Buy
135,736
+29,843
+28% +$2.03M 0.34% 79
2013
Q3 		$7.65M Sell
105,893
-94,047
-47% -$6.25M 0.3% 110
2013
Q2 		$11.2M Buy
+199,940
New +$12.5M 0.49% 42

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return